Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer’s disease

Author： Frey C.   Bonert A.   Kratzsch T.   Rexroth G.   Rösch W.   Müller-Spahn F.   Maurer K.   Müller W. E.   Eckert A.  

Publisher： Springer Publishing Company

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.113, Iss.11, 2006-11, pp. : 1753-1761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease

By Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 181-188

Humana Press, Inc

Access to resources Recommend Favorite

Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease

By Edland Steven  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 213-217

Humana Press, Inc

Access to resources Recommend Favorite

Lipid profile factors and apolipoprotein E polymorphism in Alzheimer’s disease

By Helisalmi Seppo  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-27

Future Medicine

Access to resources Recommend Favorite